The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches. [electronic resource]
- Neurologia i neurochirurgia polska 2001
- 65-8 p. digital
Publication Type: Journal Article
0028-3843
Anticonvulsants--therapeutic use Antiparkinson Agents--adverse effects Dopamine Agents--adverse effects Dyskinesia, Drug-Induced--drug therapy Excitatory Amino Acid Agents--therapeutic use Glutamic Acid--drug effects Humans Levodopa--adverse effects Parkinson Disease--drug therapy Riluzole--therapeutic use